title: Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature.
authors.affiliation: Department of Obstetrics and Gynecology, Centre Hospitalier Departemental, 85000, La Roche sur Yon, France.
authors.forename: Mathilde
authors.initials: M
authors.lastname: Vital
authors.forename: Christine
authors.initials: C
authors.lastname: Lebert
authors.forename: Jean
authors.initials: J
authors.lastname: Reignier
authors.forename: Guillaume
authors.initials: G
authors.lastname: Ducarme
mesh_terms: D000328:Adult; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000209:etiology; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D015232:Dinoprostone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D004452:Echocardiography; D005260:Female; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D058725:Peripartum Period; D006473:Postpartum Hemorrhage / Q000188:drug therapy*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D011644:Puerperal Disorders / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents; C016767:sulprostone; D015232:Dinoprostone